Skip to main content

Centric Wealth Management

Position in ABBV — AbbVie Inc.

CIK 1752761 CHICAGO, IL

Position in ABBV

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$7,037,867
+$955,107 QoQ
Shares Held
27,968
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#1,106
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Dec 31, 2021
CallValue
$311,420
CallShares
2,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Centric Wealth Management holds $27,566,757 across 6 Drug Manufacturers - General names. ABBV ranks #2 (25.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABBV
AbbVie Inc.
This page
27,968 $7,037,867

All Filings in ABBV

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,037,867 27,968
2026-03-31 $6,082,760 27,968
2025-12-31 $6,427,195 28,129
2025-09-30 $5,790,583 25,009
2025-06-30 $4,416,642 23,794
2025-03-31 $4,508,241 21,517
2024-12-31 $3,244,091 18,256
2024-09-30 $1,925,035 9,748
2024-06-30 $1,682,096 9,807
2024-03-31 $1,742,697 9,570
2023-12-31 $1,419,680 9,161
2023-09-30 $1,311,131 8,796
2023-06-30 $1,128,363 8,375
2023-03-31 $1,310,499 8,223
2022-12-31 $1,261,204 7,804
2022-09-30 $1,073,143 7,996
2022-06-30 $1,233,397 8,053
2022-03-31 $1,180,809 7,284
2021-12-31 $311,420 2,300
2021-12-31 $997,356 7,366
2021-09-30 $13,000 2,300
2021-09-30 $712,589 6,606
2021-06-30 $698,368 6,200
2021-06-30 $120,376 3,200
2021-03-31 $1,086,204 10,037
2021-03-31 $19,000 3,200
2020-12-31 $1,090,572 10,178
2020-12-31 $5,000 1,200
2020-09-30 $558,035 6,371
2020-06-30 $998,196 10,167
2020-03-31 $485,406 6,371